Bay Street News, February 24th, 2020

SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company […]

PALO ALTO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO), a clinical-stage biopharmaceutical company focused on […]

SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]

RADNOR, Pa., Feb. 24, 2020 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development […]

Geomega will be in Toronto from March 1 to 4 for PDAC at booth #2642. Come visit us and learn […]

CALGARY, Alberta, Feb. 24, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) […]

Published in Journal of Neuroimmunology, Results Highlight ANAVEX®2-73 (blarcamesine) Shown to Protect and Repair Myelin Forming CellsANAVEX®2-73 (blarcamesine) Provides optimal […]

Shareholders on the Record Date of February 20, 2020 are Entitled to Vote on the Proposed Business Combination with Diginex […]

YONKERS, N.Y., Feb. 24, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]

TORONTO, Feb. 24, 2020 (GLOBE NEWSWIRE) — INV Metals Inc. (“INV Metals” or the “Company”) (TSX:INV) provides an update to […]